Fosamax Claims

July 13, 2012

Fosamax (alendronate sodium) is a brand-name prescription drug manufactured by Merck that was first approved for use in the U.S. in 1995. Fosamax is in a class of medications called biphosphonates that increase bone density and prevent bone loss. It is used to prevent and treat osteoporosis in wome[...]

Continue Reading